Abberations in the mismatch repair genes and the clinical impact on oesophageal squamos carcinomas from a high incidence area in South Africa

Journal of Clinical Pathology

Volumn 58, Issue 3, 2005, Pages 281-284

  Naidoo, R ^a   Ramburan, A ^a   Reddi, A ^a   Chetty, R ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFORM; DNA; PHENOL; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; DNA REPAIR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; GENE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH AFRICA; BASE MISPAIRING; CHROMOSOME ABERRATION; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BASE PAIR MISMATCH; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA REPAIR; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 15044363628     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.014290     Document Type: Article

References (29)

1. Sitas F, Madhoo J, Wessie J. Incidence of histologically diagnosed cancer in South Africa, 1993-1995. In: National cancer registry of South Africa. Johannesburg: South African Institute of Medical Research, 1998.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Duesberg P, Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2003;3:202-10.
4. Jones PA. Epigenetics in carcinogenesis and cancer prevention. Ann N Y Acad Sci 2003;983:213-19.
5. Wang L, Li W, Wang X, et al. Genetic alterations on chromosome 6 and 9 of esophageal cancer tissue from China. Oncogene 1996;13:699-703.
6. Muzeau F, Flejou J, Belghiti J, et al. Infrequent microsatellite instability in oesophageal cancers. Br J Cancer 1997;75:1336-9.
7. Naidoo R, Tarin M, Reddi A, et al. Allelic imbalance and microsatellite instability in chromosomes 2p, 3p, 5q and 18q in oesophageal squamous carcinoma from South Africa. Diagn Mol Pathol 1999;8:131-7.
8. Ikeguchi M, Unate H, Maeta M, et al. Detection of loss of heterozygosity at microsatellite loci in esophageal squamous-cell carcinoma. Oncology 1999;56:64-8.
9. Kagawa Y, Yoshida K, Hirai T, et al. Microsatellite instability in squamous cell carcinomas and dysplasias of the oesophagus. Anticancer Res 2000;20:213-18.
10. Mimori K, Inoue H, Shiraishi T, et al. Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus. Oncology 2003;64:275-9.
11. Huang Y, Boynton R, Blount PL, et al. Loss of heterozygosity involves multiple tumour suppressor genes in human esophageal cancers. Cancer Res 1992;52:6525-30.
12. Peltomaki P. DNA mismatch repair and cancer. Mutat Res 2001;488:77-85.
13. Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002;20:102-9.
14. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
15. Naidoo R, Tarin M, Chetty R. A comparative microsatellite analysis of colorectal cancer in patients under 35 and over 50 years of age. Am J Gastroenterol 2000;95:3266-75.
16. Olansky L, Janssen R, Willing C, et al. Variability of the insulin gene in American blacks with NIDDM. Diabetes 1992;41:742-9.
17. Boland CR, Thibideau SN, Hamilton SR, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-59.
18. Chetty R, Simelane S. p53 and cyclin A protein expression in squamous carcinoma of the oesophagus. Pathol Oncol Res 1999;5:193-6.
19. Gamieldien W, Victor TC, Mugwanya D, et al. p53 and p16/CDKN2 gene mutations in esophageal tumours from a high-incidence area in South Africa. Int J Cancer 1998;78:544-9.
20. Du Plessis L, Dietzsch E, Van Gele M, et al. Mapping of novel regions of DMA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and colored populations of South Africa. Cancer Res 1999;59:1877-83.
21. Vos M, Adams CH, Victor TC, et al. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 2003;140:23-30.
22. Hu N, Huang J, Emmert-Buck MR, et al. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 2001;7:883-9.
23. Kagawa Y, Yoshida K, Hirai T, et al. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus. Anticancer Res 2000;20:213-17.
24. Mathew R, Arora S, Mathur M, et al. Esophageal squamous cell carcinomas with DNA replication errors (RER+) are associated with p16/pRb loss and wild-type p53. J Cancer Res Clin Oncol 2001;127:603-12.
25. Aoki T, Mori T, Du X, et al. Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer 1994;10:177-82.
26. Ogasawara S, Maesawa C, Tamura G, et al. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 1995;55:891-4.
27. Shibagaki I, Shimada Y, Wagata T, et al. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 1994;54:2996-3000.
28. Wagata T, Ishizaki K, Imamura M, et al. Deletion of 17p and amplification of int-2 gene in esophageal carcinomas. Cancer Res 1991;51:2113-17.
29. Nakashima H, Mori M, Mimori K, et al. Microsatellite instability in Japanese esophageal carcinoma. Int J Cancer 1995;64:286-9.